Skip to Content

Ampio Pharmaceuticals Inc AMPE

Morningstar Rating
$1.81 −0.04 (2.16%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AMPE is trading at a 73% discount.
Price
$1.86
Fair Value
$9.83
Uncertainty
Extreme
1-Star Price
$83.00
5-Star Price
$8.64
Economic Moat
Ksy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AMPE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.85
Day Range
$1.811.88
52-Week Range
$1.578.30
Bid/Ask
$1.82 / $1.85
Market Cap
$2.05 Mil
Volume/Avg
10,973 / 558,630

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the clinical development of Ampion and preclinical development. Its product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19-induced respiratory distress.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
17

Valuation

Metric
AMPE
Price/Earnings (Normalized)
Price/Book Value
0.27
Price/Sales
Price/Cash Flow
Price/Earnings
AMPE

Financial Strength

Metric
AMPE
Quick Ratio
3.05
Current Ratio
3.37
Interest Coverage
Quick Ratio
AMPE

Profitability

Metric
AMPE
Return on Assets (Normalized)
−73.66%
Return on Equity (Normalized)
−97.17%
Return on Invested Capital (Normalized)
−95.81%
Return on Assets
AMPE
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRWrq$552.7 Bil
VRTX
Vertex Pharmaceuticals IncFdrqpm$110.2 Bil
REGN
Regeneron Pharmaceuticals IncWjmmmr$105.9 Bil
MRNA
Moderna IncMkmpr$37.9 Bil
ARGX
argenx SE ADRDkc$23.9 Bil
BNTX
BioNTech SE ADRDxr$22.2 Bil
ALNY
Alnylam Pharmaceuticals IncHrpctg$20.5 Bil
BMRN
Biomarin Pharmaceutical IncDbvtzz$16.9 Bil
RPRX
Royalty Pharma PLC Class AXmdtqg$13.9 Bil
INCY
Incyte CorpHfrch$13.7 Bil

Sponsor Center